Enliven Therapeutics News

Enliven Therapeutics | CORRESP: CORRESP

Apr 26 22:20 ET

Enliven Therapeutics | ARS: Annual Report to Security Holders

Apr 26 16:24 ET

Enliven Therapeutics | UPLOAD: Others

Apr 24 22:16 ET

Enliven Therapeutics | CORRESP: CORRESP

Apr 18 22:20 ET

Enliven Therapeutics | CORRESP: CORRESP

Jun 29, 2023 15:30 ET

Enliven Therapeutics | UPLOAD: Others

Jun 29, 2023 09:30 ET

Enliven Therapeutics | ARS: Annual Report to Security Holders

Apr 28, 2023 16:14 ET

IMARA | CORRESP: CORRESP

Jan 19, 2023 16:00 ET

IMARA | CORRESP: CORRESP

Jan 6, 2023 19:39 ET

IMARA | UPLOAD: Others

Dec 29, 2022 16:30 ET

IMARA | CORRESP: CORRESP

Dec 19, 2022 09:04 ET

IMARA | UPLOAD: Others

Dec 7, 2022 16:30 ET

IMARA | PREM14A: Preliminary proxy statements relating to merger or acquisition

Sep 23, 2022 17:04 ET

IMARA | CORRESP: CORRESP

Apr 6, 2021 21:57 ET

IMARA | UPLOAD: Others

Apr 6, 2021 17:30 ET

Enliven Therapeutics | CERT: Others

Mar 11, 2020 10:58 ET

Enliven Therapeutics | CORRESP: CORRESP

Mar 10, 2020 10:00 ET

Enliven Therapeutics | CORRESP: CORRESP

Mar 9, 2020 15:40 ET

Enliven Therapeutics | CORRESP: CORRESP

Mar 9, 2020 15:38 ET

Enliven Therapeutics | UPLOAD: Others

Mar 9, 2020 15:09 ET